Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
Age
18–60
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
\- Body weight greater than 40 kg and less than 100 kg at screening and upon initial confinement.
You may not be if
Previous exposure to any anti-interleukin-12/23 or anti-interleukin-23 treatment.
Intention to perform strenuous exercise to which the participant is unaccustomed within one week prior to administration of study drug or during the study.
Clareo Health | Study to Evaluate the Relative Bioavailability of Two Risankizumab Drug Product Presentations in Healthy Volunteers.
